← Open Payments lookup

RAVINDER KAUR: Open Payments

NPI 1952936346 · LIVINGSTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$460 in 20 payments from 12 companies in 2025. Trend: 2023 $83 · 2024 $122 · 2025 $460

Food & beverage: $460
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.4$94
Novartis Pharmaceuticals Corporation3$62
Lilly USA, LLC2$60
Amgen Inc.2$43
Otsuka America Pharmaceutical, Inc.2$42
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28
Lundbeck LLC1$27
GlaxoSmithKline, LLC.1$25
Takeda Pharmaceuticals U.S.A., Inc.1$24
Kowa Pharmaceuticals America, Inc.1$22

Products named: REXULTI, JARDIANCE, LEQVIO, MOUNJARO, EVENITY, CAPLYTA, OFEV, TRELEGY ELLIPTA.

Industry payments across CA — which companies pay providers there.